Filing metadata

Accession number
0001178913-22-004049
Form type
Form 3
Filer
Chemomab Therapeutics Ltd.
CIK
CIK 1534248
Filed
Nov 15, 2022
Reporting period
Nov 14, 2022
Description
Initial ownership

Explore SEC Filings Hub

3 | SEC Filings Hub